Patent · US Active

Anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders

US10451633B2 · kind B2 · utility

0Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2015
Grant dateOct 22, 2019
Priority date
Expiry dateMar 24, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/564
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided are compositions that contain mammalian cells for use in detecting antibodies. The mammalian cells are modified such that they do not contain LEDGF protein. The mammalian cells are immobilized on a solid substrate. The compositions can also contain mammalian cells that contain the LEDGF protein. Methods for using the cell compositions in diagnostic approaches are included, as are kits for performing diagnostic tests.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.